Does CAPIVASERTIB Cause Rash maculo-papular? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Rash maculo-papular have been filed in association with CAPIVASERTIB (TRUQAP). This represents 0.8% of all adverse event reports for CAPIVASERTIB.
14
Reports of Rash maculo-papular with CAPIVASERTIB
0.8%
of all CAPIVASERTIB reports
1
Deaths
3
Hospitalizations
How Dangerous Is Rash maculo-papular From CAPIVASERTIB?
Of the 14 reports, 1 (7.1%) resulted in death, 3 (21.4%) required hospitalization, and 1 (7.1%) were considered life-threatening.
Is Rash maculo-papular Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CAPIVASERTIB. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does CAPIVASERTIB Cause?
Diarrhoea (278)
Rash (253)
Death (228)
Hyperglycaemia (152)
Nausea (96)
Vomiting (81)
Blood glucose increased (70)
Fatigue (67)
Malignant neoplasm progression (62)
Disease progression (61)
What Other Drugs Cause Rash maculo-papular?
SULFAMETHOXAZOLE\TRIMETHOPRIM (935)
AMOXICILLIN (871)
VANCOMYCIN (642)
PIPERACILLIN\TAZOBACTAM (629)
PANTOPRAZOLE (589)
LAMOTRIGINE (568)
ALLOPURINOL (550)
CARBOPLATIN (529)
ACETAMINOPHEN (499)
CLINDAMYCIN (484)
Which CAPIVASERTIB Alternatives Have Lower Rash maculo-papular Risk?
CAPIVASERTIB vs CAPLACIZUMAB
CAPIVASERTIB vs CAPLACIZUMAB-YHDP
CAPIVASERTIB vs CAPMATINIB
CAPIVASERTIB vs CAPREOMYCIN
CAPIVASERTIB vs CAPSAICIN